Advancing CRISPR/Cas Technology: Overcoming Challenges to Create the Ultimate Genome Editing Tool

CRISPR/Cas technology has revolutionized genome editing, offering unparalleled precision, efficiency, and versatility compared to traditional methods such as Zinc-Finger Nucleases (ZFNs) and TALENs. However, challenges such as off-target effects, inefficient delivery systems, immune responses, ethical concerns, and regulatory hurdles hinder its full potential. This thesis proposes a comprehensive framework for overcoming these limitations through advanced molecular engineering, delivery optimization, ethical standardization, and integration with emerging technologies like machine learning and base editing. By addressing these challenges, CRISPR can evolve into the most reliable, scalable, and accessible genomeediting platform, surpassing all existing alternatives and unlocking unprecedented possibilities in therapeutics, agriculture, and environmental applications.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-26
DOI
https://doi.org/10.5281/zenodo.14559527
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advancing CRISPR/Cas Technology: Overcoming Challenges to Create the Ultimate Genome Editing Tool

Zenodo (CERN European Organization for Nuclear Research)
Lipoproteins and Cardiovascular Health
article

Advancing CRISPR/Cas Technology: Overcoming Challenges to Create the Ultimate Genome Editing Tool

article en

Abstract

CRISPR/Cas technology has revolutionized genome editing, offering unparalleled precision, efficiency, and versatility compared to traditional methods such as Zinc-Finger Nucleases (ZFNs) and TALENs. However, challenges such as off-target effects, inefficient delivery systems, immune responses, ethical concerns, and regulatory hurdles hinder its full potential. This thesis proposes a comprehensive framework for overcoming these limitations through advanced molecular engineering, delivery optimization, ethical standardization, and integration with emerging technologies like machine learning and base editing. By addressing these challenges, CRISPR can evolve into the most reliable, scalable, and accessible genomeediting platform, surpassing all existing alternatives and unlocking unprecedented possibilities in therapeutics, agriculture, and environmental applications.

Zenodo (CERN European Organization for Nuclear Research)
Zero hunger
Openalex Percentile: Top 46%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advancing CRISPR/Cas Technology: Overcoming Challenges to Create the Ultimate Genome Editing Tool · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS